Anil Dudam

Anil Dudam currently serves as Senior Manager Regulatory Affairs CMC at STA Pharmaceutical, a WuXi AppTec Company, where responsibilities include authoring and reviewing CMC sections for various regulatory submissions and developing regulatory strategies for small molecules and biologics. Prior experience includes roles as Scientist II at Gossamer Bio, focusing on analytical support for NDA projects, and as Analytical Scientist II at Medefil, Inc., spearheading analytical development of parenteral formulations. Previous positions also encompass analytical roles at RiconPharma LLC, Novel Laboratories, Inc., Cherokee Pharma, pharmacare research LLC, along with earlier experience as a Medical Representative at Ranbaxy and Ajanta Pharma Ltd. Anil Dudam holds a Master of Science in Chemistry from Sacred Heart University and a Bachelor of Pharmacy from Kakatiya University.